Bio-pharma major Biocon on expansion mode.
Bio-pharma major Biocon is on an expansion mode. The biotech major plans to invest close to Rs 100 crore on its new research and development center located in Bangalore, with a window for future investments going up to Rs 200 crore in next few years.
Biocon is banking on a strong research pipeline. The company's focus on oral insulin will continue.
Biocon stock price
On September 18, 2014, at 15:45 hrs Biocon was quoting at Rs 499.95, up Rs 13.15, or 2.70 percent. The 52-week high of the share was Rs 553.70 and the 52-week low was Rs 319.00.
The company's trailing 12-month (TTM) EPS was at Rs 15.84 per share as per the quarter ended June 2014. The stock's price-to-earnings (P/E) ratio was 31.56. The latest book value of the company is Rs 120.89 per share. At current value, the price-to-book value of the company is 4.14.
Set email alert for
ADS BY GOOGLE
video of the day
Oct events litmus test for Nov upswing: Sanju Verma